Article -> Article Details

The intracranial pressure (ICP) monitoring devices are generally used for measuring the pressure developed between the brain and cranium caused by trauma or other reasons. These devices are used for monitoring the post-operative procedures among patients especially with skull injury and neurosurgery. Increasing brain and skull related accidents and trauma are fueling growth of the global intracranial pressure (ICP) monitoring market.

As per the Centers for Disease Control and Prevention (CDC), in 2017, 30% of the injury deaths are attributable to traumatic brain injury in the U.S. Additionally, the market is likely to expand on the back of continuously improving technologies coupled with robust unmet need for novel medication globally. Thanks to these factors, the global intracranial pressure (ICP) monitoring market size is estimated to expand by exhibiting a CAGR of 7.1% during the forecast period from 2015 to 2024.

However, the factors, including the high costs involved in the intracranial pressure (ICP) monitoring devices and risks of recalls, are hampering the growth of the market. For instance, recently, in 2019, the U.S. Food and Drugs Administration (FDA) announced recall of Integra LifeSciences’ MoniTorr Intracranial Pressure (ICP) External CSF Drainage and Monitoring Systems and LimiTorr Volume Limiting Cerebrospinal Fluid (CSF) Drainage System. Nonetheless, factors such as increasing investment and continuous observation of newer devices and are offering breakthroughs to the most suitable devices, which are likely to provide robust opportunities for growth in the coming years.

Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/703 

Competitive Dashboard

The prominent players operating in the global intracranial pressure (ICP) monitoring market are Terumo Corporation (U.S.), Spiegelberg GmbH & Co. KG (Germany), DePuy Synthes (U.S.), Medtronic Plc (Ireland), RAUMEDIC Inc. (Germany), Sophysa SA (France), Natus Medical Incorporated (U.S.), Boston Neurosciences (U.S.), and Integra LifeSciences Corporation (U.S.).

Segmentation:

The global intracranial pressure (ICP) monitoring market is segmented into Technique, Route of Intervention, Application, End user, Device, Region.

• Based on the Route of Intervention, the market is segmented into epidural sensor, intraventricular, and others.
• Based on the Technique, the market has segmented into invasive and non-invasive. Of these, the invasive segment is further segmented into tympanic membrane displacement (TMD) analyzer, transcranial doppler ultrasonography, optic nerve sheath diameter sonography, MRI/CT, and fundoscopy (papilledema).
• Based on the Application, the intracranial pressure (ICP) monitoring market is segregated into subarachnoid hemorrhage, intracerebral hemorrhage, traumatic brain injury, meningitis, and others.
• Based on the Device, the market is segmented into subarachnoid screws, intraventricular catheters, fiber-optic monitors, non-invasive ICP monitors, and epidural sensors. Of these, the intraventricular catheter segment accounted for the largest market share in 2017 and reached a value of USD 559.1 million in the year and is likely to remain dominant by accounting revenue of USD 922.7 Million by 2024.  
• Based on the End user, the market is segmented into trauma centers, hospitals and clinics, and others. Of these, the hospitals and clinics segment are dominating the market and is projected to reach USD 1299.5 million by the end of 2024.

Regional Insights

Geographically, the intracranial pressure (ICP) monitoring market span across regions namely, Europe, America, Asia Pacific, and the Middle East & Africa.

Get Access Full Report @ https://www.marketresearchfuture.com/reports/intracranial-pressure-monitoring-market-703 

Among all the regions, the American region is considered to lead the global intracranial pressure (ICP) monitoring market. The growth is credited to the increasing number of patients suffering from moderate to severe brain injury. Moreover, awareness regarding neurodegenerative disease coupled with the constant initiatives undertaken by the government for offering a better infrastructure is predicted to contribute to the market growth in this region.

The Asia Pacific region is considered to expand at the fastest rate owing to the presence of a large patient pool suffering from brain disorders. Moreover, government initiatives and the presence of well-established critical care centers and hospitals are further estimated to boost the market in this region.